110 related articles for article (PubMed ID: 15719401)
1. Prope tolerance with alemtuzumab.
Calne RY
Liver Transpl; 2005 Mar; 11(3):361-3. PubMed ID: 15719401
[No Abstract] [Full Text] [Related]
2. Some observations on prope tolerance.
Calne R; Watson CJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
[TBL] [Abstract][Full Text] [Related]
3. Alemtuzumab in kidney-transplant recipients.
Luan FL
N Engl J Med; 2011 Aug; 365(7):671; author reply 671-2. PubMed ID: 21848469
[No Abstract] [Full Text] [Related]
4. Finding the right job for the tool: alemtuzumab and its role in renal transplantation.
Newell KA; Cendales LC; Kirk AD
Am J Transplant; 2008 Jul; 8(7):1363-4. PubMed ID: 18557735
[No Abstract] [Full Text] [Related]
5. Alemtuzumab in kidney-transplant recipients.
Markmann JF; Fishman JA
N Engl J Med; 2011 May; 364(20):1968-9. PubMed ID: 21591949
[No Abstract] [Full Text] [Related]
6. Therapeutic tolerance--does it exist?
Calne SR
Expert Opin Biol Ther; 2005 Sep; 5(9):1143-5. PubMed ID: 16120044
[TBL] [Abstract][Full Text] [Related]
7. Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells.
Morales J; Bono MR; Fierro A; Iñiguez R; Zehnder C; Rosemblatt M; Calabran L; Herzog C; Benavente D; Aguiló J; Pefaur J; Alba A; Ferrario M; Simon W; Contreras L; Buckel E
Transplant Proc; 2008 Nov; 40(9):3223-8. PubMed ID: 19010240
[TBL] [Abstract][Full Text] [Related]
8. Campath-1H in intestinal and multivisceral transplantation: preliminary data.
Tzakis AG; Kato T; Nishida S; Levi D; Madariaga J; De Faria W; Nery J; Neff G; Kirk AD; Ruiz P
Transplant Proc; 2002 May; 34(3):937. PubMed ID: 12034248
[No Abstract] [Full Text] [Related]
9. Alemtuzumab induction in kidney transplantation.
Huang E; Cho YW; Shah T; Peng A; Hayashi R; Bunnapradist S
Clin Transpl; 2005; ():343-54. PubMed ID: 17424750
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of alemtuzumab in organ transplantation: current clinical status.
Ciancio G; Burke GW; Warque ME; Miller J
BioDrugs; 2006; 20(2):85-92. PubMed ID: 16626166
[TBL] [Abstract][Full Text] [Related]
11. Alemtuzumab (Campath-1H) in kidney transplantation.
Ciancio G; Burke GW
Am J Transplant; 2008 Jan; 8(1):15-20. PubMed ID: 18093269
[TBL] [Abstract][Full Text] [Related]
12. Liver transplant induction trial of daclizumab to spare calcineurin inhibition.
Heffron TG; Smallwood GA; Pillen T; Davis L; Martinez E; Romero R; Stieber AC
Transplant Proc; 2002 Aug; 34(5):1514-5. PubMed ID: 12176462
[No Abstract] [Full Text] [Related]
13. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.
Magliocca JF; Knechtle SJ
Transpl Int; 2006 Sep; 19(9):705-14. PubMed ID: 16918530
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation.
Clatworthy MR; Sivaprakasam R; Butler AJ; Watson CJ
Transplantation; 2007 Dec; 84(12):1563-7. PubMed ID: 18165765
[TBL] [Abstract][Full Text] [Related]
15. The impact of Campath 1H induction in adult liver allotransplantation.
Tryphonopoulos P; Madariaga JR; Kato T; Nishida S; Levi DM; Moon J; Selvaggi G; De Faria W; Regev A; Bejarano P; Khaled A; Safdar K; Esquenazi V; Weppler D; Yoshida H; Ruiz P; Miller J; Tzakis AG
Transplant Proc; 2005 Mar; 37(2):1203-4. PubMed ID: 15848669
[TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab and liver transplantation: a review.
Dhesi S; Boland B; Colquhoun S
Curr Opin Organ Transplant; 2009 Jun; 14(3):245-9. PubMed ID: 19417659
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.
Farney A; Sundberg A; Moore P; Hartmann E; Rogers J; Doares W; Jarrett A; Adams P; Stratta R
Clin Transplant; 2008; 22(1):41-9. PubMed ID: 18217904
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal antibodies in renal transplantation].
Bonvoisin C; Weekers L; Grosch S; Krzesinski JM
Rev Med Liege; 2009; 64(5-6):287-92. PubMed ID: 19642461
[TBL] [Abstract][Full Text] [Related]
19. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of rapid steroid elimination with alemtuzumab induction therapy in kidney and pancreas transplantation.
Sundberg AK; Roskopf JA; Hartmann EL; Farney AC; Rohr MS; Stratta RJ
Transplant Proc; 2005 Mar; 37(2):1294-6. PubMed ID: 15848701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
